Actuate Corp (NASDAQ:BIRT), the leading personalized insights and analytics company, announced that it will has received invitation to be present at the MySQL Meetup, which is to be held at San Francisco on May 14, 2014. Actuate Corp (NASDAQ:BIRT), shares after opening at $3.86 moved to $4.10 on last trade day and at the end of the day closed at $3.96. Company price to sales ratio in past twelve months was calculated as 1.38 and price to cash ratio as 2.32. Actuate Corp (NASDAQ:BIRT), showed a negative weekly performance of 29.45%.
On May 01, 2014, Immunomedics, Inc. (NASDAQ:IMMU), announced that it is offering to sell, subject to market and other conditions, shares of its common stock. Immunomedics, Inc. (NASDAQ:IMMU), shares fell 21.98% in last trading session and ended the day on $3.23. Immunomedics, Inc. (NASDAQ:IMMU), return on equity ratio is recorded as -37.10% and its return on assets is -30.90%. Immunomedics, Inc. (NASDAQ:IMMU), yearly performance is 34.02%.
On May 01, 2014, CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, reported financial results for the 3 months ended March 31, 2014, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR), shares moved down 9.30% in last trading session and was closed at $3.22, while trading in range of $ 3.22 – 3.60. CytRx Corporation (NASDAQ:CYTR), year to date (YTD) performance is -48.64%.
Rubicon Technology, Inc. (NASDAQ:RBCN), reported Q1 EPS of ($0.43), $0.10 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $12.95 million. Rubicon Technology, Inc. (NASDAQ:RBCN), weekly performance is -17.06%. On last trading day company shares ended up $8.51. Rubicon Technology, Inc. (NASDAQ:RBCN), distance from 50-day simple moving average (SMA50) is -30.08%. Analysts mean target Price for the company is $12.20.